RXRX 全部观点

RXRX 这一页 1 条观点条目,其中 0 条方向发生变化。

在本页筛选
排列
Ale's World of Stocks发布 2026-09-01
Top AI Biotech Stocks Set To Explode 2026
$RXRX未明确方向
RXRX是一只高风险、高潜在回报的投机性股票,其AI驱动的药物发现可能带来上行空间,但在出现商业成功之前,将面临波动性和不可靠的销售。

好了,各位,是时候结束列表了,现在来看第三只股票,这将是三只中风险最高的选择。这有点像登月计划,是其中最具投机性的选择,那就是 Recursion Pharmaceuticals,股票代码 RXRX。

All right, guys. Um, it's time to wrap up the list, though, with um stock number three now, which is actually going to be our riskiest option of the three. Um, and it's kind of a moonshot play, uh, the moonshot option of the bunch, and that is Recursion Pharmaceuticals, ticker symbol RXRX,

与 Lily 或 Fizer 不同,Recursion 不是传统的制药巨头,拥有数十种已商业化的药物,产生数百亿现金,或拥有三位数的庞大管线,而是一家 AI 优先的生物技术公司,从零开始建立,用 AI 驱动的机器学习取代手动湿实验室生物学。

who unlike Lily or Fizer, uh, Recursion is not a traditional big pharma giant with dozens of, you know, commercialized drugs already generating tens of billions in cash or some monumental pipeline in the triple digits, but rather this is an AI first biotech that was literally built from the ground up to replace manual wet lab biology with AIdriven machine learning.

已经是最早的记录
其他股票的全部观点条目
把 $RXRX 加入我的股票30 天完整试用
开始试用